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Elucidates Genetic Architecture of Crohn Disease
Duo Jiang,1 Sheng Zhong,2 and Mary Sara McPeek2,3,*
In genetic association testing, failure to properly control for population structure can lead to severely inflated type 1 error and power loss.
Meanwhile, adjustment for relevant covariates is often desirable and sometimes necessary to protect against spurious association and to
improve power. Many recent methods to account for population structure and covariates are based on linear mixed models (LMMs),
which are primarily designed for quantitative traits. For binary traits, however, LMM is a misspecifiedmodel and can lead to deteriorated
performance. We propose CARAT, a binary-trait association testing approach based on a mixed-effects quasi-likelihood framework,
which exploits the dichotomous nature of the trait and achieves computational efficiency through estimating equations. We show in
simulation studies that CARAT consistently outperforms existing methods and maintains high power in a wide range of population
structure settings and trait models. Furthermore, CARAT is based on a retrospective approach, which is robust to misspecification of
the phenotype model. We apply our approach to a genome-wide analysis of Crohn disease, in which we replicate association with 17
previously identified regions. Moreover, our analysis on 5p13.1, an extensively reported region of association, shows evidence for the
presence of multiple independent association signals in the region. This example shows how CARAT can leverage known disease risk
factors to shed light on the genetic architecture of complex traits.Introduction
Population structure is widespread in genetic association
studies. It can arise when the sample is stratified between
population subgroups, is admixed with multiple ancestral
populations, and/or contains cryptic relatedness. It is well
known that failure to properly adjust for population struc-
ture in genetic association testing can lead to severely in-
flated type 1 error rates and loss of power. Moreover, con-
trol for covariate information relevant to the phenotype
of interest can be useful in genetic association analysis.
These covariates can include clinical variables such as
sex, age, and smoking habits that can affect disease risk
as well as genetic variants known to be causal. Adjustment
for such covariates can be desirable in association testing to
protect against spurious associations due to confounding
factors, and to improve power by reducing unexplained
noise in the phenotype.1–3
Case-control studies have been a useful design for iden-
tification of genetic variants associated with complex
traits. We consider the problem of association testing of a
binary trait (such as disease status) with simultaneous
adjustment for population structure and covariates.
ROADTRIPS4 is a binary-trait association testing method
accounting for population structure, but it does not adjust
for covariates or additive polygenic effects. Methods5–9
based on the linear mixed model (LMM) approach have
recently gained much popularity. Compared to alternative
methods that model population structure as fixed ef-
fects,1,10,11 LMM accommodates simultaneous adjustment
for cryptic relatedness as well as sample stratification and
admixture, and it offers potential power gain by implicitly1Department of Statistics, Oregon State University, Corvallis, OR 97331, USA;
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The Americconditioning on associated SNPs other than the tested
SNP.12 However, LMM is primarily designed for quantita-
tive traits, and when applied to case-control data, it im-
poses a misspecified model on the binary phenotype,
which can lead to power loss. Two recently proposed
methods, LTMLM13 and LEAP,14 specifically focus on ascer-
tained case-control studies assuming known disease preva-
lence. However, LTMLM does not adjust for covariates, and
we find (see Results) that LEAP does not succeed in our
simulations.
We propose CARAT (CAse-control Retrospective Associ-
ation Test), a binary-trait association testing approach,
which accounts for relevant covariate information and
effectively controls for unknown population structure.
CARAT exploits the dichotomous nature of the trait by
modeling the phenotypic distribution using a mixed ef-
fects quasi-likelihood framework. In contrast to LTMLM
and LEAP, CARAT does not require the prevalence of
the disease to be known. We propose an estimating equa-
tion and score test approach, which is computationally
efficient for large-scale genome-wide studies. When as-
sessing significance of the test statistic, CARAT takes a
retrospective approach in which genotypes are viewed
as random under the null, conditional on the pheno-
type and the covariates. This approach renders CARAT
robust to misspecification of the phenotype model. We
perform simulation studies to evaluate the type 1 error
and power of CARAT, to compare it with existing
methods. Finally, we apply CARAT to a genome-wide as-
sociation analysis of Crohn disease (CD [MIM: 266600])
data from the Wellcome Trust Case Control Consortium
(WTCCC).2Department of Statistics, 3Department of Human Genetics
y of Human Genetics. All rights reserved.
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Material and Methods
The Mean and Variance Model Underlying CARAT
We consider a binary trait measured on a sample of n individuals
possibly subject to unobserved population structure, assuming
that genome-wide data are available. We focus on the problem
of testing for association between the binary trait and a single
SNP. LetY¼ (Y1, Y2, ..., Yn)T be a vector of the binary trait measure-
ments on the n individuals.G¼ (G1,G2, ...,Gn)T encodes the geno-
types of the sampled individuals at the tested SNP, where Gi equals
the minor allele count (0, 1, or 2) of individual i. Let X be an n by k
covariate matrix, whose ith row Xi contains an intercept term rep-
resented as 1 and the values of k  1 non-constant covariates for
individual i.
To model the phenotype vector Y conditional on G and X, we
take a quasi-likelihood approach, in which we specify only the
conditionalmean and variance structures ofY. For themean struc-
ture, we assume that, for i ¼ 1,..., n,
EðYi j X;GÞ ¼ mi; gðmiÞ ¼ Xibþ Gig; (Equation 1)
where g(,) is a known function, b is a k-dimensional column vec-
tor of the unknown fixed effects of the covariates, and g is the un-
known scalar effect of the tested SNP. We take g(,) to be the logit





in which case the linear coefficients can be conveniently inter-
preted as the size of an additive effect on the log odds scale. The
logit link function offers the additional benefit that it is applicable
to case-control samples with ascertainment with the intercept
considered a nuisance parameter.
To construct a covariance structure for Y, we aim to embed two
features that we deem essential: (1) the variance should depend on
the mean in a way that is consistent with the dichotomous nature
of the outcome and (2) assuming that overall genetic similarity
leads to phenotypic similarity, the trait measurements should be
subject to correlation due to population structure. With regard
to the first feature, one approach is to specify
U :¼ VarðY j X;GÞ ¼ G1=2SG1=2; (Equation 3)
where G ¼ diagfm1ð1 m1Þ;/;mnð1 mnÞg is an n-dimensional di-
agonal matrix and S is an n by n correlation matrix (defined as a
positive semi-definite matrix with 1s on the diagonal) that does
not involve the mean structure. Under this specification, the mar-
ginal variance is determined by the mean according to var(Yi) ¼
E(Yi)[1  E(Yi)].
An alternative approach is to add a dispersion parameter, s2> 0,
to the model, to obtain
U :¼ VarðY j X;GÞ ¼ s2G1=2SG1=2; (Equation 4)
where the marginal variance is now determined by the mean ac-
cording to var(Yi) ¼ s2E(Yi)[1  E(Yi)]. In a generalized linear or
quasi-likelihood model,15–17 a dispersion parameter is often
included in the variance structure to allow over-dispersion or un-
der-dispersion. However, as has been pointed out,18 in the case of
Bernoulli data, the dispersion parameter is not interpretable in the
context of the model, because for the binary random vector Y,
regardless of its joint distribution, the marginal distribution of
each Yi is always a Bernoulli distribution, in which case the mar-
ginal variance would be E(Yi)[1  E(Yi)] with no dispersion param-244 The American Journal of Human Genetics 98, 243–255, Februaryeter. On the other hand, in the context of genetic association
testing, a justification for possibly including a dispersion param-
eter is the fact that the true model is not known, and the disper-
sion parameter could potentially be useful for capturing additional
error due to model misspecification, in order to improve robust-
ness of the resulting association test. We will demonstrate through
simulation studies, in the context of association testing using
quasi-likelihood models, that exclusion of the dispersion param-
eter as in Equation 3 results in improved analysis over the model
in Equation 4.
For the structure specified either by Equation 3 or by Equation 4,
feature 2 can be achieved by assuming that S has two additive
components, one corresponding to individual-level variance and
the other to additive polygenic variance:
S ¼ xFþ ð1 xÞI ; (Equation 5)
whereF is an n by n correlationmatrix representing the overall ge-
netic similarity between the individuals due to population struc-
ture, I is an n-dimensional identity matrix, and x ˛ [0,1] measures
the relative importance of the two variance components.
F can be estimated based on genome-wide data, for example, by






GðsÞ  2bpsGðsÞ  2bpsT
2bps1 bps ; (Equation 6)
where S is the total number of genotypedmarkers,G(s) is the geno-
type column vector at marker s encoding the minor allele counts,
and bps is the estimated minor allele frequency (MAF). Alterna-
tively, one could use the sample variance of G(s), instead of
2bpsð1 bpsÞ, in the denominator. A caveat of using cJ for F is
that the diagonal elements of cJ might not be exactly 1, in which
case the resulting S will not be a valid correlation matrix. To solve
this problem, one could obtain an alternative estimator bF forF by
letting
bFij ¼cJij ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃcJiicJjjq for i; j ¼ 1;/;n: (Equation 7)
However, bF and cJ tend to be very close numerically when the
data do not involve severe systematic deviation fromHardy-Wein-
berg equilibrium. We consider both estimators in the simulation
studies in Results.
The model specified by Equations 1, 2, 3, and 5 will be used
for the main method we propose, CARAT. The model specified
with Equation 3 replaced by Equation 4 will be referred to as the
model with dispersion, and it is used for the alternative method
we consider, CARATd. We compare the performance of the
methods for association testing based on these two models in
the Results.
Parameter Estimation Based on Estimating Equations
For the model either with or without dispersion, we obtain param-
eter estimates by solving a system of estimating equations, as
we now describe. For simplicity, we bind the notation for the co-
variate matrix and the genotype vector to define ~X ¼ ðX;GÞ and
~b ¼ ðbT ;gÞT . For the model with dispersion, the parameters to
be estimated are ~b, x, and s2. For known x and s2, the quasi-likeli-





 ¼ DTU1ðY  mÞ; (Equation 8)4, 2016
where m ¼ mð~bÞ ¼ ðm1;/;mnÞT andD ¼ Dð~bÞ ¼ vm=v~b is a Jacobian
of the mean vector with respect to ~b. With a logit link function,
D ¼ G ~X. Setting Uð~bÞ ¼ 0 yields the generalized estimating equa-
tion for ~b given by
~X
T
G1=2S1G1=2ðY  mÞ ¼ 0; (Equation 9)
which is a system of k þ 1 nonlinear equations. To solve for ~b,
a modified Newton-Raphson algorithm with Fisher scoring17
involves iteratively updating ~b by


















Starting at an initial value for ~b estimated under a simple logistic
model with no correlation, we run this iterative procedure until
convergence to obtain b~bðxÞ for fixed x (note that Equation 9 does
not depend on s2).
To estimate the variance parameters, a common strategy is to
establish estimating equations by choosing quadratic forms and
then equating their observed values to their expected values.
Following this strategy, we propose to estimate x and s2 for known
~b using
s2ðY  mÞTG1=2S1ðF IÞS1G1=2ðY  mÞ ¼ traceS1ðF IÞ
(Equation 11)
and
s2 ¼ ðY  mÞTG1=2S1G1=2ðY  mÞ
n: (Equation 12)
The choice of quadratic forms resulting in these estimating
equations is motivated by the maximum likelihood estimators of
x and s2 in the case when ~b is known, assuming a multivariate
normal distribution for Y with the same mean and covariance
structure as the model with dispersion. Taking into account the
fact that ~b is unknown, one could alternatively use n  k  1 for
the denominator in the right side of Equation 12.
Combining Equations 9, 11, and 12 provides a scheme for joint
estimation of the parameters ~b, x, and s2. As a numerical proce-
dure, for each fixed x ˛ [0,1], we first make use of Equations 9
and 12 to obtain b~bðxÞ and bs2ðxÞ, which are then plugged into
Equation 11 to evaluate the difference between the two sides of
the equality. This difference is minimized in absolute value by a
one-dimensional search with respect to x ˛ [0,1] to locate the min-
imum point bx as an estimate for x and the corresponding b~bðbxÞ andbs2ðbxÞ as estimates for ~b and s2. When the model without disper-
sion is assumed instead, the parameters ~b and x can be estimated
by solving Equation 9 combined with Equation 11, in which s2
is set to be 1. The previously described numerical algorithm can
readily be adapted to solve these equations.Retrospective Association Testing
To detect association between the trait and the SNP of interest, we
test H0 : g ¼ 0 against H1 : gs 0. In general, the construction of a
quasi-score test statistic would involve evaluating the correspond-
ing coordinate(s) of the quasi-score function at the quasi-likeli-
hood estimates of the nuisance parameters under the null hypoth-
esis.19 In our case, for the model without dispersion parameter, we
let bm0, bU0, and bG0 denote the values of m, U, and G evaluated at
ðg;b; xÞ ¼ ð0; bb0; bx0Þ, where ðb; xÞ ¼ ðbb0;bx0Þ represents the solution
of the system given by Equations 9 and 11 when g is set to 0. (Simi-
larly, in the model with the dispersion parameter, we let bm0, bU0,The Americand bG0 denote the values of m, U, and G evaluated at
ðg;b; x;s2Þ ¼ ð0; bb0;bx0; bs20Þ, where ðb; x; s2Þ ¼ ðbb0;bx0; bs20Þ repre-
sents the solution of the system given by Equations 9, 11, and
12 when g is set to 0.) It follows that, evaluated at the null
estimates, the coordinate of Equation 8 corresponding to G
becomes
U0 :¼ GT bG0 bU10 ðY  bm0Þ: (Equation 13)
To perform a quasi-score test, one would divide U20 by its null
variance given X and G with the null estimates plugged in, and
the resulting test statistic would then be assumed to have a c21
distribution under H0. This method will be referred to as ‘‘the
prospective version of CARAT’’ (details in Appendix A). The valid-
ity of such a test would be contingent on the accuracy of the
assumed null distribution, which relies on the consistency of
the null estimators and tends to be very sensitive to misspecifica-
tion of the variance structure in the prospective model for Y. Our
simulation studies show that substantial inflation or deflation
of type 1 error rates frequently occurs in many realistic scenarios
(Table S1).
In order to achieve robust control over type 1 error, we assess sig-
nificance of the test by using a retrospective analysis, in which the
conditional distribution of the phenotype given genotype and co-
variates is considered. Under the null hypothesis of no association,
we build a quasi-likelihood model for G conditional on Y and X
specified by the following assumptions4
E0ðG j X;YÞ ¼ 2p1n and Var0ðG j X;YÞ ¼ s2gJ; (Equation 14)
where 1n is an n-dimensional column vector of 1s, p ˛ [0,1] is
the unknown ancestral MAF of the tested SNP,J is a known pos-
itive semi-definite matrix capturing overall genetic similarity
among individuals due to population structure, and s2g > 0 is
an unknown variance parameter. J can be obtained based
on genome-wide data via the estimator in Equation 6. Letbs2g ¼ 2bpð1 bpÞwith bp ¼ 0:5,G being the sample average estimator
for p. Then, the final CARAT test statistic can be defined as
T :¼ ðV
TGÞ2bs2g,VTJV with V ¼ bG
1=2
0
bS10 bG1=20 ðY  bm0Þ; (Equation 15)
where the null estimates in V are based on the model without
dispersion. Under regularity conditions, T has an asymptotic c21
distribution under the null hypothesis. A test statistic of the
same form, except that the null estimates in V are obtained from
the model with dispersion, will give rise to another valid test,
which we will refer to as the CARATd method, with the letter
d standing for ‘‘dispersion.’’
Connections with LMM
For definiteness, we first present the most commonly used version
of the LMM single-SNP association testing statistic. The method
assumes a linear mixed effects model given by
Y ¼ XbþGgþ e; e  N0;s2aFþ s2e I; (Equation 16)
where s2a and s
2
e are variance component parameters corre-
sponding to additive polygenic effects and environmental errors,
respectively. Denote by bmL and bUL the MLEs for the mean
vector, mL¼ Xb, and the covariance matrix, UL ¼ s2aFþ s2e I, of Y
based on the null model with g ¼ 0 (or alternatively the REML
estimator could be used for UL). Then the LMM test statistic is





whose null distribution is assumed to be c21.
Comparing CARAT (and CARATd) with the LMM approach, the
difference is 3-fold. First, in terms of the mean structure, CARAT/
CARATd assumes that the covariates contribute to the phenotype
linearly and additively on the logit scale, whereas LMM assumes
linearity and additivity on the original scale. We expect the former
to be more reasonable because the trait is dichotomous. The sec-
ond aspect of the difference relates to the variance structure.
LMM imposes a variance structure that is not dependent on the
mean, whereas both CARAT and CARATd assume a variance struc-
ture with two components, the marginal variance and the correla-
tionmatrix, with the first component dependent on themean and
the second one not. CARAT differs from CARATd in that, in the
former, the marginal variance is fully determined by the mean,
and in the latter it is determined by the mean only up to a scale
parameter s2. Third, LMM assesses the p values prospectively,
assuming phenotype information to be random, whereas CARAT
and CARATd can be viewed as directly taking the score test statistic
from the prospective model to be the test statistic, but evaluating
its p value in a retrospective manner assuming genotype informa-
tion to be random. We expect the retrospective approach to offer
better calibration for our method than the prospective quasi-score
test, because the retrospective quasi-likelihood model specified by
Equation 14 is much less susceptible to misspecification than the
prospective model. This is confirmed by the results in Table S1; see
also Appendix A.Simulation Studies
We conduct simulation studies to evaluate the type 1 error rates
and power of CARAT and to compare its performance with that
of CARATd and two existing methods, LMM and LEAP, for binary
trait association testing. We do not evaluate ROADTRIPS or
LTMLM because they do not account for covariates. Genotype,
phenotype, and covariate data are simulated on a sample of indi-
viduals with various population structure configurations and trait
models. In each setting, we simulate 10,000 non-causal SNPs,
which are used to correct for population structure. In addition,
we generate two causal SNPs, which are assumed to influence
the phenotype with epistasis: individuals holding at least one
copy of the minor allele at both SNPs have an elevated disease
risk compared to those who do not.
In the type 1 error simulations, we test the 10,000 non-causal
SNPs for association. For each given setting, the phenotypes are
re-simulated 100 times, and 1,000 SNPs are tested for each pheno-
type simulation. Altogether, 10 tests are performed for each of the
10,000 non-causal SNPs, totaling 100,000 replicates for the type 1
error simulations. In the power simulations, we test the first of the
two causal SNPs, and 5,000 replicates are performed with the phe-
notypes re-simulated for each replicate. For every test, the geno-
types at the untested causal SNP(s) are assumed to be unobserved.
In the implementations of CARAT and CARATd, we use cJ given
in Equation 6 as an estimator of the genetic relationship matrix
J in Equation 14, which is used to assess significance retrospec-
tively. To obtain an estimator of the correlation matrixF of Equa-
tion 5 in the trait model, we try bothcJ given in Equation 6 and bF
given in Equation 7, which is a standardized version of cJ. We
note that, theoretically, how F is estimated in the trait model
should not affect the validity of a retrospective test.246 The American Journal of Human Genetics 98, 243–255, FebruarySampled Genotypes
For the non-causal markers, the allele frequencies in different
ancestral populations or sub-populations are generated according
to the Balding-Nichols model.20 At each SNP, the ancestral allele
frequency p is drawn from a uniform distribution on [0,1], inde-
pendently across SNPs. Conditioning on p, the allele frequency
pk in population k is then drawn, independently for k ¼ 1,2,
from a Beta distribution with parameters p(1  F)/F and (1  p)
(1  F)/F, where F is the fixation index measuring genetic differen-
tiation due to population substructure. We take F ¼ 0.01 for
all simulations. In scenarios with population admixture, for
individual i who is either a pedigree founder or is unrelated to
everyone else in the sample and whose admixture proportion
from population 1 is Ai, the allele frequency at the SNP is given
by Ai , p1 þ (1  Ai) , p2. For descendants in a pedigree, SNP geno-
types are obtained by gene dropping in the pedigree. For any given
simulation scenario, the non-causal SNPs are simulated only once,
with the estimated genetic relationship matrix reused for every
simulation replicate. In addition to the non-causal SNPs, two
causal SNPs are simulated for each replicate, using the same Bald-
ing-Nichols model, with the ancestral allele frequencies set to be
0.1 and 0.5, respectively.
Trait and Covariate Models
Three non-constant covariates are included: sex, age, and another
continuous covariate with the standard Gaussian distribution. In
scenarios with only unrelated individuals, sex is a Bernoulli(0.5)
variable and age is a variable uniformly distributed on the interval
from 20 to 60. In scenarios with pedigrees, sex is fixed according to
the position in the pedigree (see Figure S1), and ages for the indi-
viduals labeled 1–16 in Figure S1 are simulated uniformly and
independently within 1.5 years of 75, 73, 46, 46, 43, 43, 40, 40,
18, 21, 15, 17, 13, 15, 12, and 9 years, respectively. In all cases,
the values of covariates are assumed to be independent across in-
dividuals and are regenerated for each phenotype simulation
replicate.
To simulate the phenotype given the genotypes, covariates, and
population structure, we consider two types of binary trait models.
The first type is the liability threshold model, which assumes that
the disease corresponds to an underlying continuous liability
distribution influenced by covariates and genetic factors with
a threshold that divides the population into affected and unaf-
fected individuals. Specifically, the phenotype Yi of individual i
is given by
Yi ¼ 1 if and only if Li > 0;
with Li ¼ Xibþ l,1ðG1;i > 0;G2;i > 0Þ þ Airþ ai þ ei;
(Equation 17)
where Yi ¼ 1 indicates that individual i is a case subject (affected)
and Yi¼ 0 indicates that i is a control subject (unaffected);Xi is the
134 covariate vector, which includes an intercept term; b contains
the fixed covariate effects; G1,i and G2,i encode the individual’s ge-
notypes at the two causal SNPs; l is a parameter scaling the effect
of the causal SNPs; 1(G1,i> 0,G2,i> 0) is an indicator function that
takes value 1 when both the causal SNPs have at least one copy of
the minor allele; ða1;.; anÞT  Nð0;s2aKÞ represents additive poly-
genic effects due to cryptic relatedness, where K is the kinship
matrix resulting from the cryptic relatedness; eii:i:d:Nð0; s2e Þ repre-
sents independent noise; Ai is the proportion of ancestry from
population 1 for the ith admixed individual; and Air is an ancestry
effect on the phenotype (see details in the next subsection). The4, 2016
ancestry term,Air, and additive polygenic effect, ai, are included in
the trait model only for some simulation scenarios, as a way to
incorporate population structure. In other scenarios, population
structure is instead introduced via ascertainment.
A second type of trait model we consider is a logistic model, in
which Yi is given by
Yi j Xi;Gi1;Gi2;Ai; ai  BernoulliðmiÞ; log
mi
1 mi
¼ Xibþ l,1ðG1;i > 0;G2;i > 0Þ þ Airþ ai:
(Equation 18)
Again, only some simulation scenarios (see details in the next
subsection) include the ancestry proportion, Ai, and additive poly-
genic effect, ai, in the logistic model to incorporate population
structure, and in other scenarios, population structure is generated
through ascertainment. In the simulations, for either generating
model, when association is tested with a given SNP, only Xi is
included as a covariate vector, whereas Ai and other SNPs are not
included as fixed-effect covariates in the fitted model.Population Structure Settings
We conduct two sets of simulations corresponding to two different
types of population structure. In the ‘‘2 Subpopulations’’ setting,
we consider a stratified population with two subpopulations,
from which we sample 1,000 case subjects and 1,000 control sub-
jects. To create sample structure, we introduce correlation between
the phenotype and subpopulation membership by ascertaining
the sample based on varying targeted proportions of case and con-
trol subjects from each subpopulation. Overall, the sample con-
tains 1,000 individuals from each subpopulation, with the propor-
tion of case subjects from the first subpopulation varying from
50% to 80%, in increments of 10%, representing settings ranging
from no stratification to profound stratification. For example, if
this proportion is 60%, then among the 1,000 case subjects, 600
are from subpopulation 1 and 400 are from subpopulation 2,
and among the 1,000 control subjects, 400 are from subpopula-
tion 1 and 600 are from subpopulation 2. On the population level
(before exercising ascertainment), the phenotype is simulated
using the models given in Equations 18 and 17, with the ancestry
effect (Air) and the additive polygenic effect (ai) removed from
both models. In the logistic model, the values for b and l are cho-
sen so as to satisfy the following conditions: (1) the three covari-
ates each explain an equal amount of variability in disease proba-
bility on the logit scale; (2) the covariates in Xi altogether explain
approximately 50% of the variability of the binary trait, with the
rest of the variability explained by the causal SNPs and the Ber-
noulli variance (or the e values, for the liability threshold model);
and (3) individuals with at least one copy of the minor allele for
both causal SNPs have a mean disease penetrance of approxi-
mately 15%, and the mean penetrance is 10% for other individ-
uals. For the liability threshold model, we choose the parameters
b, l, and s2e based on the same conditions, except that condition
1 is enforced on the liability scale, rather than on the logit scale.
In the ‘‘Admixture and Cryptic Relatedness’’ setting, individuals
are sampled from an admixed population with two ancestral pop-
ulations, with or without cryptic relatedness. When cryptic relat-
edness is not present, 2,000 individuals are simulated, with i.i.d.
admixture proportions, Ai, sampled from a uniform distribution
on [0,1], i ¼ 1,..., n. When cryptic relatedness is present, 400 ped-
igrees of size 16 (as in Figure S1) are simulated, with an admixture
proportion sampled for each pedigree (i.i.d. across pedigrees), and
with all founders of a given pedigree given the same admixtureThe Americproportion. In each simulation scenario, the admixture propor-
tions for the entire sample as well as the resulting genotypes for
the non-causal SNPs are generated only once and then retained
for all simulation replicates. In the ‘‘Admixture and Cryptic Relat-
edness’’ setting, population structure is incorporated in the trait-
generatingmodel by the ancestry effect,Air, and the additive poly-
genic effect, ai, in Equations 17 and 18, where r > 0 is a fixed
parameter common across individuals, implying different disease
prevalence values in the two ancestral populations, and conse-
quently, that the two ancestral populations will be represented
in an unbalanced way among the case subjects (and among the
control subjects). Larger values for r and s2a are associated with
more severe population structure. In the logistic model, the pa-
rameters b, l, r, and s2a are chosen to satisfy the following condi-
tions. (1) The three covariates each explain an equal amount of
variability in disease probability on the logit scale. (2) On the logit
scale, considering the total variability explained by the covariates,
the ancestry fixed effect (Air), and the additive polygenic effect
(ai), the proportion explained by the covariates achieves a speci-
fied level ranging from 0% to 100%, in increments of 20%. (3)
Of the remaining proportion of variability in (2), which we
describe as the proportion explained by ancestry, either it is
wholly explained by the ancestry fixed effect (in the case of no
cryptic relatedness) or half of it is explained by the ancestry fixed
effect and half of it is explained by the additive polygenic effect (in
the case when there is cryptic relatedness). (4) In the logistic
model, the Bernoulli variance (or in the liability threshold model,
the random error ei) explains, on average, approximately 60%
of the total variability in the binary case-control status. (5) On
average, the number of case subjects in the sample equals the
number of control subjects in the sample. And (6) for individuals
with at least one copy of the minor allele for both causal SNPs,
there is an increase of 10% in disease penetrance compared with
other individuals. For the liability threshold model, the parame-
ters are chosen based on the same criteria with conditions on
the logit scale adapted to be on the liability scale.Crohn Disease Data from WTCCC
To illustrate the use of our method, we analyze a genome-wide
association study (GWAS) dataset from the WTCCC.21 The
WTCCC1 study is a case-control GWAS undertaken in the British
population jointly by multiple research groups. The sample con-
sists of ostensibly unrelated individuals, about 2,000 case subjects
for each of 7 different diseases and 3,000 shared control subjects.
Genotyping was conducted with the Affymetrix 500K chip. We
analyze the CD data from WTCCC1. After quality control, the
data set has 1,748 case subjects and 2,938 control subjects, and a
total of 360,230 common SNPs (MAF > 0.05).
Kang et al.6 have previously argued that sample structure in the
WTCCC data is not adequately captured by a linear model with
100 PCs, although it is captured by an LMM. Additional motiva-
tion for the use of CARAT on the WTCCC data is based on our
simulation studies (see Results), which show (1) improved power
of CARAT over LMM because of the logistic mean structure of
CARAT and (2) improved type 1 error of CARAT over standard
logistic regression, with or without PCs, because of robustness to
phenotype model misspecification.
We perform single-SNP association tests using CARAT, CARATd,
and LMM. For all three methods, the covariates are sex and three
SNPs (rs11209026, rs2201841, and rs10512734), all in regions
previously reported and replicated to be associated with CD, basedan Journal of Human Genetics 98, 243–255, February 4, 2016 247
Table 1. Empirical Type I Error Rates for a Liability Threshold Trait Model with Two Subpopulations
Proportion of Cases froma Empirical Type I Error Rate of
Population 1 Population 2 CARAT CARATd LMM LOG LOG-1 LOG-10
50% 50% .0503 .0502 .0489 .0517* .0523* .0528*
60% 40% .0501 .0501 .0509 .0815* .0817* .0529*
70% 30% .0503 .0497 .0498 .169* .164* .0518*
80% 20% .0495 .0488 .0498 .287* .281* .0524*
Empirical type 1 error at level 0.05 is evaluated based on 100,000 replicates, so the standard error is 0.00069 for every entry in the table. Asterisk (*) indicates
type 1 error rates that are significantly different from the nominal level, using the z-test at level 0.05.
aA sample of 2,000 individuals, with 1,000 from each of the two subpopulations and with equal numbers of case and control subjects, is ascertained based on the
specified proportions of case subjects from each subpopulation.on extensive studies conducted independently of WTCCC1.
rs11209026 encodes the amino acid mutation c.1172G>A
(p.Arg391Gln) (GenBank: NM_153360.2) in IL23R (MIM:
607562) on chromosome 1p31 and has been associated with
CD in a number of studies.22–24 rs2201841 is also located in
IL23R, has been reported as an independent association signal
from rs11209026,22 and has been associated with CD in other
studies.24–26 rs10512734 is in 5p13.1, and both the SNP and the
region have been associated and replicated.23,27–29Results
Simulation Studies
We first evaluate the performance of LEAP based on 500
simulation replicates for each scenario. We observe that
LEAP frequently encounters algorithm failure, in which
case the program terminates without producing any asso-
ciation testing results. Note that, as a multi-step procedure,
the LEAPmethod first estimates the heritability of the trait,
which is then assumed known and plugged into subse-
quent steps that predict disease liabilities and test for
genetic association. However, the first step can yield a her-
itability estimate that is either negative or more than
100%, which is not permitted in models assumed by the
steps that follow and will crash the program. In our simu-
lation settings, LEAP has failure rates (defined to be the
empirical proportion of simulation replicates in which
the algorithm terminates without generating association
testing results) ranging from 21.4% to 92.6% depending
on the simulation scenario, with a number of settings hav-
ing failure rates greater than 50%. As a result, we are unable
to obtain reliable type 1 error rates or power comparisons
for LEAP. The reason is that failure or not of the algorithm
depends on the observed data, so the high failure rates
would be expected to introduce bias in results based on
only the successful runs. Therefore, we do not include
LEAP in any of the comparisons with other methods.
Empirical type 1 error rates of CARAT, CARATd, and
LMM are evaluated at nominal levels 0.05 and 0.001 for
both the ‘‘2 Subpopulation’’ and ‘‘Admixture and Cryptic
Relatedness’’ scenarios across a variety of settings under
two types of trait models, based on 100,000 replicates.
For comparison, we also evaluate in these settings the248 The American Journal of Human Genetics 98, 243–255, Februaryempirical type 1 error rates of standard logistic regression
(LOG), logistic regression with the leading principal
component1 (PC) of the genetic relationship matrix cJ
included as a covariate (LOG-1), and logistic regression
with the leading ten PCs included as covariates (LOG-
10). Tables 1 and 2 show the type 1 error results, at nominal
level 0.05, for the ‘‘2 Subpopulation’’ and ‘‘Admixture and
Cryptic Relatedness’’ settings, respectively, with pheno-
types generated under the liability threshold model. The
remaining type 1 error results are reported in Tables
S2–S4. These results demonstrate that all three of the
mixed-model methods (CARAT, CARATd, and LMM) effec-
tively control for population stratification and admixture
in these simulation settings. However, use of LOG, LOG-
PC1, and LOG-PC10 can lead to inflation of type 1 error
in some cases. In particular, we find that even in the
absence of population structure and relatedness (row 1 of
Table 1 and row 1 of Table 2), logistic regression with or
without PCs can have inflated type 1 error when the logis-
tic model does not hold, whereas CARAT is more robust
and has correct type 1 error in all the simulation settings.
The inflated type 1 error for the logistic regressionmethods
probably reflects, in part, the fact that the logistic model is
misspecified when the true model is a liability threshold
model. In contrast, CARAT is robust to phenotype model
misspecification because of the retrospective assessment
of significance. These results suggest that CARAT is prefer-
able to logistic regression, with or without PCs, even when
the amount of population structure and/or relatedness is
low (or absent).
Power results for CARAT, CARATd, and LMM based on
5,000 replicates at level 0.001 are shown in Figure 1. We
do not include LOG, LOG-1, or LOG-10 in these power
simulations, because these methods do not maintain
robust control over type 1 error. For all of the simulation
settings, CARAT consistently has the highest power. In
particular, CARAT achieves a power gain over LMM that
is statistically significant and often substantial under
different trait models and with widely ranging extent of
population structure of different types.
One question of interest is whether or not including the
dispersion parameter (as in CARATd) provides improve-
ment over the CARAT method. In fact, we find the4, 2016
Table 2. Empirical Type I Error Rates for a Liability Threshold Trait Model with Population Admixture and Cryptic Relatedness
% Variance due toa
Cryptic Relatedness
Empirical Type I Error Rate of
Ancestry Covariates CARAT CARATd LMM LOG LOG-1 LOG-10
0% 100% no .0491 .0492 .0499 .0512 .0514* .0522*
20% 80% no .0493 .0492 .0497 .188* .189* .0526*
20% 80% yes .0510 .0511 .0507 .106* .107* .0106*
40% 60% no .0496 .0492 .0493 .110* .111* .0520*
40% 60% yes .0500 .0499 .0507 .127* .126* .0125*
60% 40% no .0497 .0497 .0501 .316* .316* .0524*
60% 40% yes .0488 .0489 .0489 .163* .163* .162*
80% 20% no .0496 .0495 .0497 .350* .350* .0514*
80% 20% yes .0492 .0494 .0496 .182* .182* .0182*
100% 0% no .0506 .0506 .0512 .369* .369* .0524*
100% 0% yes .0513 .0514* .0514* .195* .195* .195*
Empirical type 1 error at level 0.05 is evaluated based on 100,000 replicates, so the standard error is 0.00069 for every entry in the table. Asterisk (*) indicates type
1 error rates that are significantly different from the nominal level, using the z-test at level 0.05.
aThe percentages are defined to be the variance, on the liability scale, explained by either the ancestry effects (admixture and cryptic relatedness) or the covariate
effects, divided by the total variance explained by the two types of effects, indicating the relative impact of ancestry versus covariates on the phenotype.opposite to be true: CARAT has consistently higher empir-
ical power than CARATd in all simulation scenarios. We
also observe that the power difference tends to grow as
population structure becomes stronger, and in the special
case where there is no population structure, CARAT and
CARATd perform almost identically. We propose a likely
reason for this in the context of a logistic trait model as fol-
lows. In the absence of population structure, the quasi-like-
lihood trait model is a correctly specified model for the
sample. It follows that, in the case of no population struc-
ture, CARATd can estimate s2g in a consistent fashion to be
close to the true value 1. Therefore, almost nothing is lost
by including this redundant nuisance parameter, provided
that the sample size is large. As population structure
strengthens, however, the prospective model becomes
more subject to misspecification, and the estimated s2g is
no longer close to 1, resulting in the divergence of the per-
formance of CARAT and CARATd.
For the ‘‘2 Subpopulation’’ settings, in which the misca-
libration of the LOG-10 statistic is not extreme, we also
compare the power of LOG-10 and CARAT for detecting as-
sociation under either the liability threshold or logistic
phenotype model. To make a fair power comparison, we
first use 500,000 simulated replicates under the null model
to recalibrate both statistics to have correct type 1 error.
The results, reported in Table S5, show that CARAT consis-
tently outperforms LOG-10 in terms of power, as well as in
type 1 error (Tables 1 and S2) in this scenario.
In the results presented, the correlation matrix F of
Equation 5 in the trait model is estimated by cJ given
in Equation 6. Use of the alternative estimator, bF of Equa-
tion 7, for F produces very similar results in all scenarios
(results not shown for brevity).The AmericAnalysis of Crohn Disease Data from WTCCC
Genome-wide association testing for CD is performed on
360,230SNPsusingCARAT,CARATd, andLMM,withadjust-
ment for covariates (sex and three SNPs previously identified
as associated), as described inMaterial andMethods. The re-
sulting genomic control inflation factors for the three
methods are lGC ¼ 1.002, 1.002, and 1.004, respectively.
Table 3 shows the 17 genetic regions with at least one SNP
for which the p value is less than 106 using at least one of
the three tests. All 17 regions identified by our analysis
have previously been associated with CD or inflammatory
bowel disease (IBD [MIM: 266600]). These include many
extensively replicated loci and genes.23,30–34 For example,
at 16q12.1, a cluster of associated SNPs are within or in close
proximity toNOD2 (CARD15 [MIM: 605956]), awell-known
CD-susceptibility gene.30,34–36 The associated SNPs in the
2q37.1 region are close to ATG16L1 (MIM: 610767), which
has been widely associated with CD.21,32
In Table 3, a somewhat surprising result is that there is
still significant association with a SNP in 5p13.1, even
though rs10512734, a known risk SNP from the same re-
gion, has been controlled for as a covariate in the analysis.
In fact, after rs10512734 is controlled for, four SNPs in
close proximity of rs10512734 retain evidence of associa-
tion (Table 4). In Table 4, we compare the p values of these
SNPs based on the analyses with and without rs10512734
included as a covariate (in both analyses, we keep sex and
the other two covariate SNPs, rs11209026 and rs2201841,
as covariates). We observe that adjustment for rs10512734
results in a boosted association signal for three of the
nearby SNPs. For example, rs6883686, which is 8,928
base pairs from rs10512734, shows no evidence of associa-
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Figure 1. Empirical Power of CARAT, CARATd, and LMM
Empirical power is based on 5,000 replicates. An upper bound for the standard error of the empirical power is 0.007. For a difference
between two empirical power values, the upper bound on the standard error is 0.01.
(A and B) Power results in the ‘‘2 Subpopulations’’ setting, in which the leftmost value on the horizontal axis (50%/50%) corresponds to
no population stratification and the rightmost value (80%/20%) corresponds to profound stratification. Power results when the pheno-
type is generated according to a liability threshold model with two subpopulations (A) or to a logistic regression model with two sub-
populations (B).
(C and D) Power results in the ‘‘Admixture and Cryptic Relatedness’’ setting, for which the percentages on the horizontal axis are defined
so that the numerator is the variance, on the liability or logistic scale, explained by the ancestry and cryptic relatedness effects (the first
number) or by the covariate effects (the second number), and the denominator is the total variance explained by the two types of effects.
The horizontal scale indicates the relative impact of ancestry versus covariates on the phenotype, with the far left corresponding to no
effect of ancestry and strong effects of covariates and the far right corresponding to no effect of covariates and a strong effect of ancestry.
The dotted lines denote settings with cryptic relatedness, and the solid lines denote settings without cryptic relatedness. Power results
when the phenotype is generated according to a liability threshold model (C) or according to a logistic regression model (D) in the
‘‘Admixture and Cryptic Relatedness’’ setting.After adjusting for rs10512734, however, suggestive evi-
dence of association is found for rs6883686, with a dra-
matic change in the p value from 0.99 to 5.1 3 104 using
CARAT. To investigate the association signals in 5p13.1
more closely, we include each of the individual SNPs in
5p13.1 that are present in the data as a covariate and
examine the p values of the other SNPs. We find that no
single SNP within 5p13.1 is able to explain all the associa-
tion signal in this region. These results suggest either that
the 5p13.1 region contains more than one independently
associated SNP or that there exists at least one untyped CD250 The American Journal of Human Genetics 98, 243–255, Februarysusceptibility variant in this region that is not well tagged
by any single SNP in the dataset.
To further investigate the possibility of untyped causal
SNPs in 5p13.1, we obtain dense genotype data through
imputation based on the phase 3 data of the 1000
Genomes project.37 We apply MaCH38,39 to phase the
WTCCC genotype data and use Minimac340,41 for geno-
type imputation. We examine all SNPs present in the
1000 Genomes data that are located in a 20 Mb region
around 5p13.1 to determine whether the association signal
in that region can be attributed to any single imputed SNP.4, 2016
Table 3. Regions of Strongest Association with Crohn Disease in WTCCC Data
Region Top SNP Positiona CARAT CARATd LMM
1p13.1 rs12078461 117,273,572 4.7 3 1015* 4.8 3 1015* 5.8 3 1010
1q41 rs1933641 216,535,584 1.0 3 1017* 1.0 3 1017* 1.8 3 1011
2p12 rs11887827 81,519,665 9.5 3 107 9.8 3 107 2.3 3 107*
2q37.1 rs10210302 233,823,578 4.4 3 1012 4.4 3 1012 1.7 3 1012*
3p24.3 rs9839841 16,454,562 1.7 3 1016 1.6 3 1016 4.1 3 1017*
4p15 rs1553460 17,804,959 <1018 <1018 <1018
5p13.1 rs17234657 40,437,266 3.7 3 108 3.8 3 108 1.8 3 108*
5q23.1 rs2416472 117,033,845 2.6 3 1010 2.6 3 1010 3.0 3 1010
7p14.1 rs1525791 39,123,083 7.9 3 107 8.1 3 107 5.8 3 107
10q21.2 rs10761659 64,115,570 6.1 3 107 6.1 3 107 6.5 3 107
10q24.2 rs10883371 101,282,445 3.4 3 107 3.4 3 107 2.7 3 107
11q23.2 rs17116117 113,306,801 <1018 <1018 <1018
14q13.2 rs10483456 35,105,918 6.3 3 1016 6.4 3 1016 6.0 3 1016
16p11.2 rs4471699 30,227,808 7.6 3 1013 7.6 3 1013 1.1 3 1013*
16q12.1 rs2076756 49,314,382 5.9 3 1012* 6.1 3 1012* 2.4 3 1011
18p11.21 rs2542151 12,769,947 9.4 3 109* 9.6 3 109* 2.1 3 108
219q13.2 rs41537748 44,449,412 2.2 3 108* 2.2 3 108* 6.3 3 108
Association results are based on an analysis adjusting for sex and three known associated SNPs (rs11209026, rs2201841, and rs10512734) as covariates. Asterisk
(*) indicates a p value less than half of the largest of the p values yielded by the three methods.
aBase pair position is based on assembly NCBI36.Specifically, we include each of the imputed SNPs as a co-
variate (sex is included as an additional covariate) when
testing the other SNPs, typed and imputed, within
5p13.1. We find that no single imputed SNP in the region
is able to fully explain the association signal at 5p13.1.
Among the imputed SNPs, the smallest CARAT p value,
1.2 3 1012, is achieved by two SNPs in perfect LD in the
imputed data, located at 40,410,043 and 40,410,739 on
chromosome 5, respectively. After adjusting for these two
SNPs, there remain additional association signals in
5p13.1, with the smallest p value, 4.8 3 106, achieved
by a typed SNP, rs11957215. Overall, our results indicate
the presence of multiple susceptibility variants within
5p13.1. The 5p13.1 region has previously been reported
and replicated as associated with CD,23,27 and evidence
has been found that variants in this region correlate with
the expression level of PTGER4 (MIM: 601586),23 a gene
that has been implicated in IBD in murids. We are the first
to report evidence suggesting the existence of multiple
independent risk variants within 5p13.1.
The aforementioned observation illustrates that, in asso-
ciation mapping, including known associated SNPs as co-
variates has the potential to enable discoveries of new asso-
ciation signals and to generate interesting insights into the
genetic architecture of the trait. More examples are pro-
vided in Table 5, which compares the p values using
models with no covariates and those using models with
sex and three SNPs as covariates.The AmericComputation Time
The main computational burden of implementing CARAT
comes from the eigendecomposition of the genetic rela-
tionship matrix. Despite the potential complexity of this
decomposition, its impact on the computational feasibility
of the method is mitigated by two factors: (1) the decom-
position incurs no extra cost beyond LMM and PC-based
methods, which require the same decomposition or one
of comparable computational complexity;1,8,9 (2) it needs
to be done only once per genome scan. Once the eigende-
composition is available for the genetic relationship ma-
trix, the additional computational cost of CARAT is O(n2)
for fitting the null model and O(n) for calculating the test
statistic. As for LMM, the time complexity can be further
reduced in the case of a low-rank genetic relationship
matrix.8 Overall, CARAT enjoys the same computational
scalability as LMM8,9 in large genetic association data.
CARAT is implemented in a freely downloadable
software package (see Web Resources). We report some
example run times of CARAT for analysis of real and simu-
lated data. Using a single processor on a machine with 6
core Intel Xeon 3.50 GHz CPUs and 32 GB RAM, CARAT
takes less than 6 s to fit the null model on the WTCCC
data with 4,686 individuals, and approximately 131 s to
analyze a total of 360,230 genome-wide SNPs, assuming
the genetic relationship is available. For a sample of
20,000 individuals, fitting the null models takes 107 s,
and the genome-wide analysis takes an additonal 9.4 minan Journal of Human Genetics 98, 243–255, February 4, 2016 251
Table 4. Association Signals at 5p13.1 in WTCCC Data
SNP Position
Controlled for
rs10512734? p Value via CARAT
rs10473185 40410924 yes 1.8 3 106
no 1.0 3 104
rs10512734 40429362 yes –
no 1.7 3 107
rs17234657 40437266 yes 3.7 3 108
no 4.5 3 1013
rs6883686 40438290 yes 5.1 3 104
no .99
rs6885315 40465299 yes 5.2 3 104
no .93
After rs10512734 is included as a covariate (together with three other covari-
ates), four SNPs in close proximity still show association signal. p values for
these SNPs are compared with andwithout adjusting for rs10512734. For three
of these SNPs, controlling for rs10512734 boosts association signal.
Table 5. Including Covariates Can Help Boost Association Signal
Chr SNP Covariatesa Included? p Value via CARAT
5 rs12657249 yes 1.8 3 106
no 5.3 3 104
18 rs12966840 yes 9.6 3 109
no 1.8 3 107
18 rs1942868 yes 1.0 3 107
no 1.2 3 106
18 rs9954415 yes 6.7 3 108
no 8.1 3 107
19 rs10421478 yes 2.1 3 108
no 1.7 3 107
aWe compare p values based on the analysis with no covariates with those
based on the analysis with the following covariates: sex, rs11209026,
rs2201841, and rs10512734.(566 s). These results demonstrate that CARAT computes
rapidly for large-scale genome-wide association studies.Discussion
Population structure is a widespread confounding factor in
genetic association studies. It is well known that failure to
account for population structure can lead to both false pos-
itives and false negatives in genetic association mapping.
We have developed CARAT, an association testing method
for binary traits in samples with population structure.
Compared to existing methods such as ROADTRIPS and
LTMLM, CARAT features the ability to account for covari-
ate information. Like LMM, CARAT includes an additive
polygenic variance component to account for population
structure. Unlike LMM, CARAT specifically accommodates
binary traits by modeling covariate effects on the logit
scale and by accounting for the dependence of the variance
on the mean. As a result, CARAT gains power over LMM in
case-control association testing. Moreover, we take an esti-
mating equation and score test approach, which ensures
that CARAT is computationally rapid for large-scale
studies. In addition, CARAT uses a retrospective analysis
to assess significance of the test statistic, which equips
the method with robustness to misspecification of the
phenotype model. We provide a computationally efficient
implementation of CARAT in a freely downloadable soft-
ware package.
We demonstrate the validity and power of CARAT
through simulation studies. In particular, CARAT consis-
tently outperforms LMM under diverse simulation sce-
narios with different types of trait models, widely ranging
levels of covariate effects, and varying degrees of popula-
tion stratification and admixture. In our simulations, we
found the recently developed program LEAP to be unsta-252 The American Journal of Human Genetics 98, 243–255, Februaryble, as reflected in frequent failures that prevented the al-
gorithm from producing association testing results. There-
fore, we were not able to compare LEAP with the other
methods. We compare CARAT to logistic regression with
or without PCs included as covariates. We find that CARAT
ismore robust tomisspecification of the phenotypemodel,
while the type 1 error of the logistic regression methods
can be inflated in the presence of model misspecification.
In addition to demonstrating the improvement of CARAT
over previously proposed methods, we also consider the
question of whether there is any benefit to including a
dispersion parameter in the CARAT model. To test this,
we develop CARATd, a version of CARAT that includes
the dispersion parameter.We find that the power of CARAT
is consistently higher than that of CARATd in our simula-
tions, suggesting that the dispersion parameter should not
be included in the model.
We applied CARAT to association mapping of CD in the
WTCCC dataset. In the analysis, we included as covariates
sex and three known associated SNPs: rs11209026,
rs2201841, and rs10512734. We found 17 CD-associated
regions, all of which have been previously associated
with CD or with a closely related phenotype, IBD. In addi-
tion, we observed in the CD analysis that adjusting for rele-
vant covariates can enhance the ability to detect associa-
tion and can lead to interesting insights into the genetics
of a disease. In particular, by including known associated
SNPs as covariates, we have found evidence that 5p13.1
might contain multiple independent associated SNPs.
Although the trait model assumed by CARAT uses a logit
link function, the method is adaptable to other link func-
tions as deemed appropriate. Ideally, a good choice of the
link function should provide a scale on which the covari-
ate effects are additive. As an example, the complementary
log-log linkmight be considered when the case-control sta-
tus in the data is asymmetric, which might be the case if
the binary trait is a truncation of some unobserved count4, 2016
(for instance, ‘‘no tumor’’ versus ‘‘some tumors,’’ where the
number of tumors is the unobserved count). Moreover,
CARAT can be generalized to the analysis of non-binary
traits by assuming Equation 1 and
VarðY j X;GÞ ¼ s2G1=2SG1=2;
where G ¼ diagfVðm1Þ;/;VðmnÞg;
where the link function g(,) in Equation 1 and themarginal
variance functionV(,)in the equation above can be chosen
based on amarginal distribution from the exponential fam-
ily tailored to the data type under consideration. For
example, to analyze Poisson count data, one could use
g(m) ¼ log(m) and V(m) ¼ m. We note that although CARAT
sets the dispersion parameter s2 to be 1 for binary traits, it
could be beneficial to include s2 as a free parameter for
non-binary data to capture possible over-dispersion.
In our presentation of CARAT, the genetic relationship
matrix F in Equation 5 is estimated based on either Equa-
tion 6 or 7. However, the method is able to accommodate
other choices. For example, Yang et al.12 show that the po-
wer of LMM can be improved by estimating the genetic
relationship matrix using genome scan data with the
tested SNP excluded. The same strategy can be applied in
CARAT. In addition, CARAT can be adapted to incorporate
more than two additive correlation components in S, with
the extra variance component parameters estimated using
estimating equations constructed in a similar way as for
Equation 11. It has been argued that including additional
variance components could provide improved protection
against spurious association with highly differentiated
SNPs42 and could provide simultaneous adjustment for
multiple levels of sample structure including population
stratification and familial relatedness.5 Furthermore,
CARAT can be combined with methods that model popu-
lation structure as fixed effects, such as EIGENSTRAT, by
including inferred ancestry information as covariates.
Recently, the GCAT method, which models genetic vari-
ation in structured populations, has been described.43 In
the context of quantitative traits, GCATwas shown to pro-
vide an advantage for association analysis in the presence
of population structure, compared to LMM and linear
regression with PCs included as covariates. For binary
traits, Song et al.43 do not show their simulation results,
but report that ‘‘all methods performed similarly well in
terms of producing correct P values that were robust
to structure,’’ indicating that GCAT does not provide
improvement over existing methods for binary traits.
Furthermore, the way in which covariates would be incor-
porated for a binary trait in GCAT is not explicitly
described in Song et al. Our results on CARAT indicate
that when covariates play an important role for a binary
trait, the way that covariates are incorporated can affect
power. Specifically, when covariate effects are large, a logis-
tic model for the effect of covariates on the trait is more
successful than a linear one in providing high power for
association.The AmericFor testing associationwith rare variants, all themethods
we compare (LMM, CARAT, CARATd, and logistic regres-
sion with PCs) will encounter similar challenges. One po-
tential problem that has been pointed out44 is that in
some cases, rare variants might have different population
histories than common variants, so genetic relationship
matrices and PCs calculated based on common variants
might not be applicable to rare variants. Low MAF of the
tested variant does not by itself cause problems for any of
these analysis methods when the sample size is sufficiently
large.However, if theminor allele countof a testedvariant is
too low, the asymptotic assumptions underlying the assess-
ment of significance for CARAT, for example, might fail.Appendix A: Type I Error with the Prospective
Version of CARAT
Based on the prospective quasi-likelihood model described
in Material and Methods and Equation 6, the prospective




where K ¼ bG0 bU10 bG0. To perform the association test with
the prospective version of CARAT, we assume that Tpro fol-
lows a c21 distribution under the null hypothesis. The accu-
racy of this null distribution is not robust against misspeci-
fication of the prospective model. Our simulation studies
show that under many realistic scenarios, the prospective
version of CARAT does not offer correct control over type
1 error. Examples of such scenarios are shown in Table S1.Supplemental Data
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found with this article online at http://dx.doi.org/10.1016/j.ajhg.
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